메뉴 건너뛰기
Lancet Oncology
Volumn 7, Issue 10, 2006, Pages 786-787
Keynote comment: Radiotherapy in the age of molecular oncology
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; NEW DRUG;
EID: 33749050567     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(06)70871-3     Document Type: Letter
Times cited : (15)
References (8)
  • 1
    • 4544384318 scopus 로고    scopus 로고
    • Radiation oncology: a century of achievements
    • Bernier J., Hall E., and Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer 4 (2004) 737-747
    • (2004) Nat Rev Cancer , vol.4 , pp. 737-747
    • Bernier, J.1    Hall, E.2    Giaccia, A.3
  • 2
    • 0141540770 scopus 로고    scopus 로고
    • Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial
    • Overgaard J., Hansen H., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362 (2003) 933-940
    • (2003) Lancet , vol.362 , pp. 933-940
    • Overgaard, J.1    Hansen, H.2    Specht, L.3
  • 3
    • 28844492570 scopus 로고    scopus 로고
    • Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?
    • Andreassen C. Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?. Acta Oncol 44 (2005) 801-815
    • (2005) Acta Oncol , vol.44 , pp. 801-815
    • Andreassen, C.1
  • 4
    • 13344277921 scopus 로고    scopus 로고
    • Theragnostic imaging for radiation oncology: dose-painting by numbers
    • Bentzen S. Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol 6 (2005) 112-117
    • (2005) Lancet Oncol , vol.6 , pp. 112-117
    • Bentzen, S.1
  • 5
    • 33748190361 scopus 로고    scopus 로고
    • Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy
    • Krause M., Zips D., Thames H., et al. Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy. Radiother Oncol 80 (2006) 112-122
    • (2006) Radiother Oncol , vol.80 , pp. 112-122
    • Krause, M.1    Zips, D.2    Thames, H.3
  • 6
    • 4644335081 scopus 로고    scopus 로고
    • Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results
    • Baumann M., and Krause M. Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results. Radiother Oncol 72 (2004) 257-266
    • (2004) Radiother Oncol , vol.72 , pp. 257-266
    • Baumann, M.1    Krause, M.2
  • 7
    • 32144433159 scopus 로고    scopus 로고
    • Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
    • Bonner J., Harari P., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578
    • (2006) N Engl J Med , vol.354 , pp. 567-578
    • Bonner, J.1    Harari, P.2    Giralt, J.3
  • 8
    • 22444441668 scopus 로고    scopus 로고
    • Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project
    • Bentzen S., Heeren G., Cottier B., et al. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. Radiother Oncol 75 (2005) 355-365
    • (2005) Radiother Oncol , vol.75 , pp. 355-365
    • Bentzen, S.1    Heeren, G.2    Cottier, B.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.